Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)
NCT02661568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38409
Last updated 2016-01-22
Summary
This study will utilize a retrospective cohort design. Using the Clinical Practice Research Datalink (CPRD) linked with Hospital Episode Statistics (HES) datasets, all patients with a record of VTE diagnosis between 1 April, 2008 and 31 March, 2013 will be identified and followed from the occurrence of VTE (index date) to the first of 24 months after the index date, end of the study period, leaving the database, or death.
Conditions
- Venous Thromboembolism
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients
NCT03243708 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis
NCT03265054 ·Status: UNKNOWN
-
Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism
NCT04124159 ·Status: UNKNOWN
-
Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
NCT05150314 ·Status: UNKNOWN
-
Monitoring Trends in Venous Thromboembolism
NCT00063518 ·Status: COMPLETED
-
Treatment Patterns Among Patients With Venous Thromboembolism in the United States
NCT05795062 ·Status: COMPLETED
-
Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge
NCT00604370 ·Status: COMPLETED
-
Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
NCT04439383 ·Status: COMPLETED
-
A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness
NCT05819112 ·Status: TERMINATED
-
Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)
NCT02297373 ·Status: COMPLETED
-
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
DVT Burden and the Risk of Post-thrombotic Syndrome
NCT06385353 ·Status: RECRUITING ·Phase: NA
-
Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data
NCT05264168 ·Status: COMPLETED
-
Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy
NCT02979561 ·Status: UNKNOWN ·Phase: PHASE4
-
Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients
NCT01401725 ·Status: COMPLETED ·Phase: NA
-
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
NCT05396157 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric Patients
NCT01140386 ·Status: COMPLETED
-
Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome
NCT02904967 ·Status: COMPLETED ·Phase: NA
-
Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.
NCT01958203 ·Status: COMPLETED
-
Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
NCT01446510 ·Status: WITHDRAWN
-
Epidemiology of Venous Thromboembolism
NCT00456196 ·Status: COMPLETED
-
Understanding Risk Factors Involved in Developing a Second Blood Clot.
NCT00261014 ·Status: UNKNOWN
-
Timing of VTE Prophylaxis in TBI
NCT03081169 ·Status: WITHDRAWN ·Phase: PHASE4
-
A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient
NCT03114618 ·Status: COMPLETED